Assyro AI is an AI-powered regulatory copilot designed to transform how pharmaceutical and biotech companies prepare and submit regulatory documentation. By combining advanced drafting assistance, real-time eCTD/RPS validation, and deep regulatory intelligence, Assyro helps teams accelerate submission timelines, minimize compliance risk, and reduce costly rework. Its platform delivers clause-level guidance and audit-ready trails tailored for drugs and biologics, enabling regulatory, publishing, and compliance leaders to draft faster, validate more efficiently, and submit with confidence.

Assyro gives regulatory teams a secure, AI-native way to move from manual, error-prone submission workflows to faster, data-driven operations that are always inspection ready. By combining clause-level regulatory intelligence with high-speed, local eCTD validation and transparent audit trails, it helps pharma and biotech organizations accelerate approvals, reduce compliance risk, and scale global submissions without adding headcount.